CytoBioscience develops and manufactures instrumentations that support ion channel research and new approaches to disease analysis and individualized treatment modalities. The company’s devices allow other researchers, medical institutions, and pharmaceutical companies to understand how human cells react to medicines. It offers services in the areas of expression systems, adult human heart, cardiac action potentials, chronic exposures, and custom assays; and provides consumables, such as cell lines, iPS cells, microchips, buffers, and solutions. CytoBioscience was formerly known as Cytocentrics AG. The company was founded in 2001 and is based in Rostock, Germany.